• Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub
  •  0 items - £0.00
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • My account
  •  0 items - £0.00

Action Duchenne

Header Right

  • Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub

News

You are here: Home / News

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

25 February 2025 by Lizzie Cox

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44 Entrada Therapeutics, today announced that the United States Food and …

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44Read More

Family Science Education Day and Charity Dinner Dance

14 February 2025 by Lizzie Cox

Family Science Education Day and Charity Dinner Dance Join us for a Family Day at Birmingham's Think Tank Science Museum followed by a Charity …

Family Science Education Day and Charity Dinner DanceRead More

Action Duchenne launches Webinar Series 2025

11 February 2025 by Lizzie Cox

Action Duchenne launches Webinar Series 2025 Action Duchenne brings a great initiative to further support the Duchenne community through their …

Action Duchenne launches Webinar Series 2025Read More

Action Duchenne Expands All-Through Support into Scotland

6 February 2025 by Lizzie Cox

Action Duchenne Expands All-Through Support into Scotland PRESS RELEASE FOR IMMEDIATE RELEASE: Action Duchenne to deliver vital support to …

Action Duchenne Expands All-Through Support into ScotlandRead More

SMC Recommends Vamorolone for Treating DMD in Scotland

13 January 2025 by John Marrin

Action Duchenne welcomes the exciting news from the Scottish Medicines Consortium’s (SMC) positive recommendation for vamorolone for the treatment of …

SMC Recommends Vamorolone for Treating DMD in ScotlandRead More

Merry Christmas and Happy New Year from Action Duchenne

23 December 2024 by Lizzie Cox

…

Merry Christmas and Happy New Year from Action DuchenneRead More

MHRA approves Givinostat as a treatment for Duchenne muscular dystrophy

20 December 2024 by Mehreen Arif

Action Duchenne is pleased to share great news with the Duchenne community. Givinostat has been approved by the Medicines and Healthcare products …

MHRA approves Givinostat as a treatment for Duchenne muscular dystrophyRead More

Edgewise Therapeutics Announces Positive Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy 

17 December 2024 by John Marrin

Edgewise Therapeutics, announced positive topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular dystrophy. …

Edgewise Therapeutics Announces Positive Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy Read More

NICE Recommends Vamorolone for Treating DMD in England

10 December 2024 by John Marrin

Action Duchenne is excited to share the news that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance …

NICE Recommends Vamorolone for Treating DMD in EnglandRead More

REGENXBIO Announces Pivotal Phase of AFFINITY DUCHENNE Clinical Trial for RGX-202 

5 December 2024 by John Marrin

REGENXBIO, a leading clinical-stage biotechnology company focused on advancing transformative gene therapies, announced in late November that the …

REGENXBIO Announces Pivotal Phase of AFFINITY DUCHENNE Clinical Trial for RGX-202 Read More

Empowering lives on International Day of Persons with Disabilities

3 December 2024 by Lizzie Cox

As we mark International Days of Persons with Disabilities today, 3rd December, we are delighted to share significant milestones in our ‘All-through …

Empowering lives on International Day of Persons with DisabilitiesRead More

Givinostat Early Access Programme Launches for Duchenne Muscular Dystrophy Patients

15 November 2024 by John Marrin

Summary We are excited to announce that Givinostat, a new HDAC (histone deacetylase) inhibitor treatment currently under regulatory review, is now …

Givinostat Early Access Programme Launches for Duchenne Muscular Dystrophy PatientsRead More

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Interim pages omitted …
  • Page 49
  • Go to Next Page »

Footer

Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA

0300 102 1762
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

Site Footer

Fundraising Regulator badge with validation link

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852